Delta, Kelowna, BC – August 19, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,
www.potcasts.ca
release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #598, Cannabis News and Stocks on the Move; (TSX: VLNS), (CSE: BHSC) (CSE: HARV) (OTCQX: HRVSF), (CSE: XTRX)
SHARE PODCAST:
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
BioHarvest Sciences Inc.’s (
CSE: BHSC
)
today unveiled
a new, groundbreaking “Amalgamated Trichomes Coral Structure” (ATCS) that will revolutionize the production of Cannabis. BioHarvest has successfully grown multiple trichomes in coral-shaped clusters where they are attached together in a natural structure. This structure protects the trichomes from the shear forces and guarantees much-needed mechanical stability during the growth process.
The trichomes (the natural cannabinoids micro-factories of the Cannabis plant – picture 3) grow on the surface of the Cannabis flower or leaf and have a shape of a tiny mushroom with glandular heads.
They are individually and mechanically attached to the surface through a fragile stalk. BioHarvest is the first company in the world to successfully and naturally grow trichomes together, forming a coral-shaped structure (pictures 1 and 2) that protects them from the shear forces applied by the fluid motion inside the bioreactors. This structure guarantees the much-needed mechanical stability during the growth process within the bioreactor. We call this uniquely shaped structure “Amalgamated Trichomes Coral Structure” (ATCS), and it allows the Company to quickly scale up Cannabis production in advance of wide scale commercialization in H1 2022.
Dr. Yochi Hagay, CTO of BioHarvest, said: “ATCS is instrumental in the ability to grow trichomes cells in bioreactors at scale. Over the last decade, BioHarvest’s world-class R&D team demonstrated unparalleled expertise in plant cell biology. This achievement is particularly notable given the complexity of Cannabis, and I have no doubt in this team’s ability to apply it on any plant in the future.”
Ilan Sobel, CEO of BioHarvest, said: “ATCS brings us one step closer to the completion of the Cannabis development program. The patented BioFarming technology, along with such in-house expertise, is creating tremendous biotech market opportunities for BioHarvest. I look forward to showing the world in H1/2022 the Company’s Cannabis-based products and to unveiling new conquered frontiers by our BioFarming technology.”
Eitan Popper, Chairman of BioHarvest’s Board of Advisors, and Co-Founder and former President of MedReleaf, stated: “One of the main questions I raised when I first met BioHarvest’s management, was whether the Company’s technology would allow for Cannabis trichomes to stably grow in liquid media. Even intuitively, this is far from trivial, as Cannabis trichome cells grown in liquid media lack the static mechanical support they have when growing on top of or attached to the solid Cannabis flower or leaf tissue. The challenge is two-fold, not only liquid media vs. solid plant tissue but also dynamic flow conditions vs. static conditions. Put simply, how do you stably proliferate and guarantee the physical integrity of fragile plant organs grown in a liquid that is circulating or flowing within a bioreactor. BioHarvest has solved this with proprietary IP that is specific to Cannabis. It is fascinating from a scientific point of view and very encouraging from a business potential perspective for Cannabis and beyond.”
The Valens Company Inc. (
TSX: VLNS
) (
OTCQX: VLNCF
), a leading manufacturer of cannabis products,
today announced
that its subsidiary Green Roads has entered into a third-party distribution agreement with Tele Marche Co., Ltd. for the sale and distribution by Tele Marche Co of Green Roads’ award-winning CBD products in Japan.
Tele Marche Co, in consultation with Green Roads, developed an online store in Japan by leveraging insights and best practices from Green Roads’ strong e-commerce and marketing platform in the US, which averages approximately 9,000 orders per month and boasts over 30,000 five-star product reviews. The online store in Japan also includes various educational resources to help consumers learn more about cannabidiol (CBD), the importance of lab testing for safety and quality, and how to choose a product that best suits their preferences.
“We are very excited to join forces with Tele Marche Co so that they can bring Japanese consumers our award-winning CBD products that many consumers in the United States and beyond have come to trust for their quality, consistency, and value,” said Dale Baker, President, US of The Valens Company. “We are confident that this new online store, along with its robust consumer education, will meet the growing needs of Japanese CBD consumers and will achieve success similar to that of our US e-commerce platform.”
A full range of Green Roads’ CBD products are now available to Japanese consumers through the online store, including tinctures, pet products, gummies, chocolate, bath bombs, and capsules. The online store in Japan will be owned and operated by Tele Marche Co under license from Green Roads.
Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company added: “We are incredibly proud to add Japan to the growing list of countries in which Green Roads’ products are available. With a population of approximately 127 million1, we view Japan as a significant growth opportunity with untapped potential for leading North American CBD brands like Green Roads. With Green Roads and Valens’ products now collectively available in over 12 countries, we are rapidly increasing our distribution exposure and strategically positioning our platform to service many emerging markets poised for significant growth in new global regions.”
Harvest Health & Recreation Inc. (
CSE: HARV
) (
OTCQX: HRVSF
), a vertically integrated cannabis company and multi-state operator in the U.S.,
today announced
that it has obtained the final order from the Supreme Court of British Columbia approving the previously announced arrangement agreement, pursuant to which Trulieve Cannabis Corp. has agreed to acquire all of the issued and outstanding shares of Harvest.
“We are pleased to have reached another milestone as we work toward closing the Trulieve transaction,” said Chief Executive Officer Steve White. “We have and will continue to work collaboratively with the entire Trulieve team until we obtain all of required regulatory approvals needed to close.”
This follows the company
announcing
the opening of a new medical dispensary in Philadelphia, Pennsylvania.
Harvest of South Philadelphia is located at 501 South Broad St, Philadelphia and is open Monday through Saturday from 9:00 am to 8:00 pm and Sunday from 10:00 am to 6:00 pm.
More information for patients about the new medical dispensary location can be found at:
https://www.harvesthoc.com/locations/pennsylvania/philadelphia/harvest-of-philadelphia-broad/
Additional Harvest-affiliated dispensaries in Pennsylvania are located in Camp Hill, Cranberry Township, Harrisburg, Johnstown, King of Prussia, Reading (two locations), Scranton, Whitehall, and York.
“We are pleased to open our eleventh Harvest-affiliated dispensary in Pennsylvania, one of the fastest growing medical markets in the U.S.” said Chief Executive Officer Steve White. “We look forward to serving patients and providing quality products at this new location in one of our core markets.”
Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (
CSE: XTRX
)
announced
that it has submitted a licence amendment to Health Canada that, if approved, will enable Phyto to sell dried cannabis flower to provincially authorized distributors and retailers and registered medical patients.
The licence amendment would allow Phyto’s wholly owned Health Canada licenced subsidiary, Adastra Labs Inc., to leverage its agricultural product fulfillment capabilities to package, produce and sell dried flower based products across Canada, which would open the pathway to higher profit margins by eliminating the necessity to sell to other licence holders.
Michael Forbes, CEO and a director of Phyto, states, “The ability to sell dried cannabis products directly to provincial distributors and retailers represents a major milestone in the development of Phyto’s growth-oriented business plan. Direct sales will increase margins and provide critical access to retail space as flower and pre-rolls represent the largest cannabis market segments in Canada while bringing more eyes to our brands.”
Dried Cannabis products are in high demand from provincial distributors and medical clients. Sales continue to dominate the legal Canadian recreational market, accounting for roughly three quarters of all sales and totaling over $2 billion in 2020.1″We intend to leverage Phyto’s brand awareness and sales momentum in the concentrates space to commercialize dried cannabis products under the brand to drive topline revenue with these high gross margin products,” said Donald Dinsmore, COO, Corporate Secretary and a director of Phyto.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at
https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit:
https://www.investorideas.com/Audio/
.
The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Investors can trade these stocks and other ideas on our site using our
list of top stock trading apps
including Robinhood, Acorn, Stash and others.
About Investorideas.com – News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns:
Crypto Corner
,
Play by Play
sports and stock news,
Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
,
Cleantech and Climate Change
,
Exploring Mining
,
Betting on Gaming Stocks Podcast
and the
AI Eye Podcast
.
Disclaimer/Disclosure:
Investorideas.com
is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific questions.
More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/
and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://www.instagram.com/investorideas_potcast/
Download our
Mobile App
for iPhone and Android
Contact Investorideas.com
800-665-0411
